Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
- PMID: 34493492
- PMCID: PMC11034903
- DOI: 10.1136/annrheumdis-2021-221206
Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
Keywords: COVID-19; autoimmune diseases; epidemiology; vaccination.
Conflict of interest statement
Competing interests: DLS has the following financial disclosures: consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, Thermo Fisher Scientific. LC-S has the following financial disclosures: consultant fees from Janssen, Boehringer-Ingelheim, Mallinckrodt, EMD-Serono, Allogene and ArgenX.
References
-
- Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021. Jun 15:L21–0282. doi: 10.7326/L21-0282. Epub ahead of print. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous